Samantha Pearce Takes The Helm As Jazz Pharmaceuticals' Chief Commercial Officer

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that Samantha Pearce, currently Senior Vice President (SVP) for Europe and International, will assume the role of Chief Commercial Officer (CCO) starting August 1, 2024. Ms. Pearce, who joined Jazz in 2020 as SVP for Europe and International, brings over three decades of commercial experience in the pharmaceutical sector. During her tenure, she has fostered a culture of high performance and significantly expanded Jazz's commercial footprint, leveraging the company's European and International operations to deliver innovative therapies to patients in over 50 countries. As CCO, she will oversee strategy and operations for Jazz's global commercial activities, with her base located in the United States.

Renée Galá, President and Chief Operating Officer, Jazz Pharmaceuticals, commented "Sam is an inspiring leader with an established track record of effectively scaling commercial operations to achieve transformational growth and accelerated patient access to medicines across geographies. Her remarkable talent for unifying teams around a shared vision and cultivating a culture of performance and innovation will significantly enhance our global commercial business, and I am thrilled to welcome Sam to this newly created role."

Ms. Pearce also stated that "I am delighted to be stepping into the role of CCO and look forward to leading the combined commercial organization as we continue to scale. I am deeply invested in Jazz's mission and purpose to help patients and remain focused on our commitment to deliver sustainable growth and enhanced value as an innovative global biopharmaceutical company. I have had the privilege of leading Jazz's Europe and International organization since 2020 and look forward to continuing to partner closely with talented Jazz colleagues to unlock the potential of our business and deliver innovative, life-changing medicines for people with serious diseases.”

Between March 2010 and December 2019, Ms. Pearce held various leadership roles spanning global markets at Celgene Corporation, culminating in her position as Vice President and General Manager overseeing international markets. Before her tenure at Celgene, from August 2002 to March 2010, she held progressive commercial management roles at AstraZeneca plc, including her role as Director of Specialist Care. Earlier in her career, she gained experience at DuPont Pharmaceuticals. Ms. Pearce earned a B.Sc. from Birmingham University, U.K., and an M.B.A. from Cranfield University, U.K.